Fertility sparing treatment Guidelines – ESGO Gynae-Oncology Guidelines

ESGO-ESHRE-ESGE Guidelines of fertility sparing treatment in endometrial cancer patients

The European Society of Gynaecological Oncology (ESGO) together with the European Society of Human Reproduction and Embryology (ESHRE) and the European Society for Gynaecological Endoscopy (ESGE) developped clinically relevant and evidence-based guidelines focusing on key aspects of fertility-sparing treatment in order to improve the quality of care for women with endometrial carcinoma across Europe and worldwilde (patients selection, tumour clinicopathological characteristics, treatment, special issues).

The multidisciplinary international group involved expert practising clinicians and researchers in the fields of gynecological oncology, human reproduction, endoscopy, and histopathology.

The development group was chaired by Prof. Alexandros Rodolakis (ESGO, Greece), Dr. Kirsten Louise Tryde Macklon (ESHRE, Denmark) and Prof. Giovanni Scambia (ESGE, Italy).

The article was published in IJGC on 6 February, 2023.

You can read the article here:

ESGO-ESHRE-ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma

ESGO-ESHRE-ESGE Pocket guidelines